Premium
Can Fite BioPharma Ltd (CANF)
AMEX
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III t... Can Fite Biofarma Ltd is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease. The company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH). Show more
RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs...
RAMAT GAN, Israel , Oct. 07, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule...
The agreement has been signed upon successful conclusion of a clinical study in dogs with osteoarthritis RAMAT GAN, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE...
Study will aim to establish safety and clinical efficacy PETACH TIKVA, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.5 | 25.3807106599 | 1.97 | 2.55 | 1.91 | 162269 | 2.22814292 | CS |
| 4 | 0.06 | 2.48962655602 | 2.41 | 2.55 | 1.8661 | 134890 | 2.11650899 | CS |
| 12 | -1.42 | -36.5038560411 | 3.89 | 4.69 | 1.8661 | 111708 | 2.59085596 | CS |
| 26 | 0.16 | 6.92640692641 | 2.31 | 4.69 | 1.8661 | 89667 | 2.75145168 | CS |
| 52 | 0.06 | 2.48962655602 | 2.41 | 4.69 | 1.81 | 74174 | 2.51445323 | CS |
| 156 | -12.53 | -83.5333333333 | 15 | 26 | 1.52 | 435947 | 16.22597138 | CS |
| 260 | -19.03 | -88.511627907 | 21.5 | 56.1 | 1.52 | 704101 | 21.10053305 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| YANGDirexion Daily FTSE China Bear 3X Shares New | US$ 3,187 (-1,64%) | 93,9M |
| FXIiShares China Large Cap | US$ 33,45 (0,69%) | 69,11M |
| SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 38,67 (2,22%) | 58,43M |
| XLFFinancial Select Sector | US$ 46,51 (1,93%) | 51,9M |
| SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 18,96 (-2,27%) | 47,86M |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
